1. Academic Validation
  2. Tnk1/Kos1 knockout mice develop spontaneous tumors

Tnk1/Kos1 knockout mice develop spontaneous tumors

  • Cancer Res. 2008 Nov 1;68(21):8723-32. doi: 10.1158/0008-5472.CAN-08-1467.
Sarasija Hoare 1 Kishalay Hoare Mary K Reinhard Young J Lee S Paul Oh W Stratford May Jr
Affiliations

Affiliation

  • 1 Department of Medicine, University of Florida Shands Cancer Center, Gainesville, Florida 32610-3633, USA.
Abstract

Tnk1/Kos1 is a non-receptor protein tyrosine kinase implicated in negatively regulating cell growth in a mechanism requiring its intrinsic catalytic activity. Tnk1/Kos1 null mice were created by homologous recombination by deleting the catalytic domain. Both Tnk1(+/-) and Tnk1(-/-) mice develop spontaneous tumors, including lymphomas and carcinomas, at high rates [27% (14 of 52) and 43% (12 of 28), respectively]. Tnk1/Kos1 expression is silenced in tumors that develop in Tnk1(+/-) mice but not in adjacent uninvolved tissue, and silencing occurs in association with Tnk1 promoter hypermethylation. Tissues and murine embryonic fibroblasts derived from Tnk1/Kos1-null mice exhibit proportionally higher levels of basal and epidermal growth factor-stimulated Ras activation that results from increased Ras-guanine exchange factor (GEF) activity. Mechanistically, Tnk1/Kos1 can directly tyrosine phosphorylate growth factor receptor binding protein 2 (Grb2), which promotes disruption of the Grb2-Sos1 complex that mediates growth factor-induced Ras activation, providing dynamic regulation of Ras GEF activity with suppression of Ras. Thus, Tnk1/Kos1 is a tumor suppressor that functions to down-regulate Ras activity.

Figures